Three Respiratory Trial Strategies That Won’t Leave You Breathless

Clinical trials that collect respiratory endpoints are among the most expensive to conduct.  In such a competitive environment where recruiting patients is increasingly difficult and costly, data from all patients need to actively contribute to the success of the study and overall development program.

In this peer-reviewed article, ERT’s Phil Lake, PhD, reviews three strategies that will help sponsors and CROs cut the time and cost of their trials while improving respiratory data quality.  Read the full article below, or download it here.

ERT_3_Respiratory_Strategies_JCS_Sep_2017 (1)